Corteva, Inc. business relationships

“Bayer alleged that Corteva practiced two Bayer patents in developing Enlist E3® soybeans, and therefore, is entitled pursuant to the terms of the cross-license agreement to royalties for sales between 2019 through 2029, along with interest.” SEC filing

“| | | SpecCo/AgCo Intellectual Property Cross-License Agreement, effective as of June 1, 2019, by and among DowDuPont Inc., Corteva, Inc. and the other parties identified therein (incorporated by reference to Exhibit 10.1 to Corteva's Current Report on Form 8-K (Commission file number 001-38710), fi...” SEC filing

“| | | Intellectual Property Cross-License Agreement by and between Corteva, Inc. and Dow Inc. (incorporated by reference to Exhibit No. 10.4 to Amendment 3 to Corteva's Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019). |” SEC filing

“The company is dependent to a certain extent on DuPont and Dow to maintain and enforce certain of the intellectual property licensed under the Intellectual Property Cross-License Agreements.” SEC filing

“Any material adverse effect upon Corteva's ability to own or sell such customer receivables, including seasonal factors that may impact the amount of customer receivables Corteva owns, may materially impact Corteva's access to capital.” SEC filing

“In addition, Corteva supplements this approach with strong retail channels, including distributors, agricultural cooperatives and dealers, and with digital and data solutions that assist farmer decision-making with a view to optimize their product selection and maximize their yield and profitability...” SEC filing

“They also have the first right to enforce their respective trade secrets and know-how licensed to Corteva.” SEC filing

“| | | Intellectual Property Cross-License Agreement by and between Corteva, Inc. and Dow Inc. (incorporated by reference to Exhibit No. 10.4 to Amendment 3 to Corteva's Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019). |” SEC filing

“Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization.” SEC filing

“launched Etlas, a joint venture with Corteva,” SEC filing

“from this collaboration are expected to be further developed by Corteva (see Customer A in Note 21c).” SEC filing

“In November 2024, Lavie Bio terminated its licensing agreement with Corteva.” SEC filing

“collaboration with Corteva for the discovery and development of novel herbicides.” SEC filing

“Intellectual Property Cross-License Agreement, dated as of April 1, 2019, by and among Dow Inc. and Corteva, Inc. (incorporated by reference to Exhibit 10.4 to Dow Inc.'s Current Report on Form 8-K filed with the SEC on April 2, 2019).” SEC filing

“On May 14, 2024, Arcadia sold its non-GMO Resistant Starch ("RS") durum wheat trait to longtime partner Corteva Agriscience ("Corteva") for total cash consideration of $4.0 million.” SEC filing

“On July 13, 2015, we and Pioneer Hi-Bred International, Inc. ("Pioneer") (now Corteva Agriscience), then a DuPont company ("DuPont"), entered into an Amended and Restated Collaboration and License Agreement (as amended, "Pioneer Agreement").” SEC filing

“Our CRISPR chRDNA genome-editing patent family was developed under a three-year research collaboration between us and Pioneer, now Corteva Agriscience.” SEC filing

“As of July 2023, we also entered into an exclusive distribution agreement with Corteva to advance the availability of a bioinsecticide developed by Pro Farm in Europe.” SEC filing

“Our joint ventures with industry leaders, such as Florimond Desprez and De Sangosse, and non-joint venture collaborations with companies such as Syngenta, Corteva and Momentive, have allowed us to bring our products to market in an efficient and cost-effective manner.” SEC filing